BridgeBio Pharma (BBIO) Return on Sales [ROS] (2020 - 2026)
BridgeBio Pharma (BBIO) posted Return on Sales [ROS] of -3.30% for Q3 2026, up 117.00 percentage points from -120.30% a year earlier and up 40.65 percentage points from the prior quarter.
BridgeBio Pharma (BBIO) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Return on Sales [ROS] at BridgeBio Pharma was -38.52%, up 133.87 percentage points year-over-year; for FY2025, it came in at -104.25%, up 162.97 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of +5647.74 percentage points (FY2020 to FY2025).
- In prior years, BridgeBio Pharma's Return on Sales [ROS] was -267.22% in FY2024 (+6261.53 pp), -6528.75% in FY2023 (-5869.11 pp), -659.65% in FY2022 (+167.47 pp) and -827.12% in FY2021 (+4924.88 pp).
- The Q3 2026 figure stands as the highest quarterly Return on Sales [ROS] since Q1 2024.
- On a year-over-year basis, Return on Sales [ROS] has increased in each of the last six quarters, with an average year-over-year change of +3136.27 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2021, with a gain of 103213.96 percentage points; the weakest was Q3 2022, with a drop of 31822.06 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -43.94% (Q2 2026), -54.47% (Q1 2026) and -90.52% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | BridgeBio Pharma | 15.42 Bn | 11.64 Bn | 332.72 Mn | -3.30% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -3.30% |
| Jun 30, 2026 | -43.94% |
| Mar 31, 2026 | -54.47% |
| Dec 31, 2025 | -90.52% |
| Sep 30, 2025 | -120.30% |
| Jun 30, 2025 | -121.45% |
| Mar 31, 2025 | -89.49% |
| Dec 31, 2024 | -3,842.69% |
| Sep 30, 2024 | -7,018.67% |
| Jun 30, 2024 | -8,096.82% |
| Mar 31, 2024 | 0.16% |
| Dec 31, 2023 | -10,167.11% |
| Sep 30, 2023 | -3,854.61% |
| Jun 30, 2023 | -8,903.05% |
| Mar 31, 2023 | -6,909.26% |
| Dec 31, 2022 | -6,910.80% |
| Sep 30, 2022 | -38,200.00% |
| Jun 30, 2022 | -108.72% |
| Mar 31, 2022 | -10,252.54% |
| Dec 31, 2021 | -1,285.22% |
BridgeBio Pharma Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();